Objective. Interleukin-6 (IL-6) is a multifunctional cytokine affecting gro
wth and survival of normal B cell lineage and multiple myeloma cells. To te
st the hypothesis that IL-6, as well as other hematopoietic growth factors,
may enhance apoptosis of target cells, we investigated the effect of IL-6
on myeloma cells in the presence of IFN-alpha, which is prescribed for pati
ents with multiple myeloma.
Materials and Methods. Four myeloma cell lines, PCM6, NOP-2, U266, RPM18226
were tested. We determined the induction of apoptosis by flow cytometry, u
sing an FITC-Annexin V.
Results. IFN-alpha induced apoptosis on myeloma cell lines, and this apopto
sis was further enhanced in the presence of IL-6, via activation of caspase
3. During induction of this apoptosis, the expression of c-Myc and Fas inc
reased. The addition of IL-6 further increased the expression of Fas, but n
ot that of c-Myc. Bcl-2, Bcl-x, and p53 were not affected by the addition o
f IL-6 and/or IFN-alpha. Addition of a PI-3-K inhibitor interfered with the
enhancing effect of IL-6 on the apoptosis induced by IFN-alpha.
Conclusion. We propose that IL-6 has the death signal, as well as growth pr
omoting effects, and that PI-3-K may play a key role in the induction of ap
optosis by IL-6. (C) 2000 International Society for Experimental Hematology
. Published by Elsevier Science Inc.